Clinical Trials Browser

Phase 3 × Unknown × ibritumomab tiuxetan × Clear all

NCT01827605 2023-12-14

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Phase 3 Unknown

Lymphoma, Follicular

NCT00463463 2012-07-12

Zevalin

Phase 3 Unknown

Lymphoma, Non-Hodgkin